Remifentanil (Remifentanil Teva)
Remifentanil
Teva Pharmaceuticals (Pty) Ltd
Every registration of this product has been cancelled.
Registration
- Applicant
- Teva Pharmaceuticals (Pty) Ltd
- Registrations
- 3
- Schedule source
- Consolidated Schedules 06 July 2026
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Remifentanil teva 1 EACH VIAL CONTAINS REMIFENTANIL HYDROCHLORIDE EQUIVALENT TO REMIFENTANIL 1,0 mg | 1 | 45014745/2.9/0147 | Cancelled | S6 | None |
| Remifentanil teva 2 EACH VIAL CONTAINS REMIFENTANIL HYDROCHLORIDE EQUIVALENT TO REMIFENTANIL 2,0 mg | 2 | 45014845/2.9/0148 | Cancelled | S6 | None |
| Remifentanil teva 5 EACH VIAL CONTAINS REMIFENTANIL HYDROCHLORIDE EQUIVALENT TO REMIFENTANIL 5,0 mg | 5 | 45014945/2.9/0149 | Cancelled | S6 | None |
Regulatory status
Where S6 sits on the scale
Prescription-only, no repeats without a new prescription.
Schedule 6 covers the most tightly controlled ordinary prescription medicines. Every dispensing needs its own new prescription; nothing can be repeated on the same script. When prescribed, the quantity must be written out in both figures and words. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S6, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it.
Consolidated Schedules listings for Remifentanil hydrochloride equivalent to remifentanil
S6: Remifentanil
Consolidated Schedules 06 July 2026, line 10423
Pharmacological class: Other analgesics. (class 2.9)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Methyl 1-(3-methoxy-3-oxopropyl)-4-(N-propanoylanilino)piperidine-4-carboxylate
Drag to rotate. Structure from PubChem CID 60815.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.